CD99 isoforms regulate CD1a expression in human monocyte-derived DCs through ATF-2/CREB-1 phosphorylation

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• CD1a expression is a key marker for in vitro human dendritic cells (DCs).
• The regulation of CD1a transcription during DC generation is not fully understood.
• CD99 protein exists in two isoforms: long form (CD99LF) and short form (CD99SF).

Purpose of the Study:

• To investigate the role of CD99 isoforms in regulating CD1a transcription in human DCs.
• To elucidate the molecular mechanisms by which CD99 isoforms control CD1a expression.
• To understand the implications of CD99 alternative splicing in DC differentiation and immune response.

Main Methods:

• Utilized lentiviral short hairpin RNA to inhibit CD99 expression in primary human DCs.
• Quantified CD1a membrane expression and CD1A transcript abundance.
• Analyzed the expression levels of CD99 isoforms during DC generation.
• Investigated the role of the ATF-2 transcription factor in CD99-mediated CD1a regulation.

Main Results:

• Inhibition of CD99 expression led to increased CD1a membrane expression and higher CD1A transcript levels.
• CD1A transcription correlated with a switch from CD99LF to co-expression of both CD99 isoforms during DC differentiation.
• CD99LF down-regulates CD1A transcription by up-regulating phosphorylated ATF-2.
• CD99SF is necessary to counteract the suppressive effect of CD99LF on CD1A transcription.

Conclusions:

• CD99 alternative splicing is a critical regulatory mechanism for CD1a transcription in human DCs.
• The balance between CD99LF and CD99SF dictates CD1a expression levels during DC differentiation.
• Understanding this mechanism provides insights into DC development and immune responses.